Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

American Funds SMALLCAP World 529A

CSPAXNASDAQ
NaN
NaN
$77.91
$0.82(1.06%)
U.S. Market is Open • 15:45

American Funds SMALLCAP World 529A Fundamental Analysis

American Funds SMALLCAP World 529A (CSPAX) shows weak financial fundamentals with a PE ratio of 24.73, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.
We analyze CSPAX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
0.0/100

We analyze CSPAX's fundamental strength across five key dimensions:

Efficiency Score

Weak

CSPAX struggles to generate sufficient returns from assets.

ROA > 10%
N/A

Valuation Score

Moderate

CSPAX shows balanced valuation metrics.

PE < 25
24.73
PEG Ratio < 2
N/A

Growth Score

Moderate

CSPAX shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

CSPAX carries high financial risk with limited liquidity.

Debt/Equity < 1
N/A
Current Ratio > 1
N/A

Profitability Score

Weak

CSPAX struggles to sustain strong margins.

ROE > 15%
N/A
Net Margin ≥ 15%
N/A
Positive Free Cash Flow
N/A

Key Financial Metrics

Is CSPAX Expensive or Cheap?

P/E Ratio

CSPAX trades at 24.73 times earnings. This indicates a fair valuation.

24.73

How Well Does CSPAX Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How CSPAX Stacks Against Its Sector Peers

MetricCSPAX ValueSector AveragePerformance
P/E RatioN/A23.90 N/A
ROEN/A27.00% N/A
Net MarginN/A-30345.00% (disorted) N/A
Debt/EquityN/A0.76 N/A
Current RatioN/A27.92 N/A
ROAN/A967.00% N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews American Funds SMALLCAP World 529A's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Blend, Diversified, Stable

EPS CAGR

N/A

Industry Style: Blend, Diversified, Stable

FCF CAGR

N/A

Industry Style: Blend, Diversified, Stable

Fundamental Analysis FAQ